Riders For The Cure - Working to Cure Cancer

  • Increase font size
  • Default font size
  • Decrease font size

Sam’s Jam III

Event Date: October 16th, 2010

Our third annual ride benefiting The University of Texas MD Anderson Cancer Center happened on October 16th, 2010. The event is named Sam’s Jam III after one of the founding members of Riders for the Cure, the Employee Motorcycle group of MD Anderson Cancer Center.

This year’s donations will be funding the Gliogene Project. Gliogene is the largest study ever to be conducted on malignant primary brain tumors, known as gliomas. Researchers aim to screen approximately 15,000 individuals worldwide during the five-year study.

With Gliogene, we may be able to learn more about possible genes related to this disease - and then identify a genetic link among family members of brain tumor patients.

Identifying a genetic link may provide information about the disease - information that one day we hope will lead to improved treatment, as well as prevention strategies.

 

Upcoming Rides

Ride for Life 2012:

June 2nd, 2012 at 9:30 A.M.

Ride For Life, a police-escorted motorcycle ride, will take place Saturday, June 2nd 2012.

Registration for this ride starts at 9:30 a.m., and kickstands go up at 11am. The cost is $20 per rider, which includes lunch, and a pin. The ride will start and end at Stubbs Harley-Davidson in Houston on Telephone Road. There will be door prizes, food and entertainment.

Read More? View Our Online Flyer Register Here

Sam’s Jam V:

October 13th, 2012

This will be the 5th year for Sam's Jam and we look forward to seeing everyone at the event.

Mark your calendars!

View Our Online Flyer

Studies Currently Supported...

STUDIES SUPPORTED

Phase I/II study of reirradiation of recurrent or progressive brainstem glioma:

 

This study investigates the use of re-irradiation in the highly aggressive form of cancer known as brainstem glioma. This Phase I/II study will be conducted to evaluate the safety of re-irradiation with higher doses. The main goal of treatment will be to improve symptoms and quality of life. This protocol may identify the optimal dose of re-irradiation and define the efficacy, particularly regarding quality of life, therefore offering a treatment option for patients with an incurable disease.

 

Principal Investigators: Anita Mahajan, M.D. and Hiral P Fontanilla, M.D.